Mental Health DailyResearch. Evidence. Perspective.Published research on nmda antagonist.
A 2026 retrospective case series of 22 adults with treatment-resistant depression and comorbid PTSD found that trauma re-experiencing during intranasal esketamine disappeared over later sess…
Read articleKetamine and its S-enantiomer esketamine (sold as Spravato) are now established treatments for treatment-resistant depression and acute suicidality. The standard safety pitch from sponsors a…
Read articleMagnesium is regarded as an essential mineral for humans and functions as a cofactor in upwards of 300 biochemical processes throughout the body. For example, magnesium is implicated in: ATP…
Read articleNamenda (Memantine) is a drug that was approved by the FDA in 2003 for the treatment of Alzheimer’s disease. Research suggests that Namenda has a small effect in reducing symptoms among thos…
Read articleKetamine is a drug that is used to induce sedation in humans in a controlled environment. It is also used recreationally and is referred to as “Special K.” Ketamine is an NMDA antagonist tha…
Read articleLanicemine (AZD6765) is an NMDA antagonist developed by the company AstraZeneca in hopes to help people with treatment-resistant depression. Let’s face it, if you have treatment-resistant de…
Read article
